FILTER

FILTERED INTERVIEW RESULTS

Mining
Mali
MACIG

Larry Phillips

CEO, COMPASS GOLD
MACIG 2022
Compass Gold explains progress at its Sikasso property in Mali.
Mining
Australia
Cote d’Ivoire
Ghana
Burkina Faso
MACIG

Peter De Leo

MANAGING DIRECTOR, LYCOPODIUM LIMITED
MACIG 2022
Lycopodium is an ASX-listed global engineering and project delivery organisation from Perth, Australia with operations across Africa.
Mining
Mali
MACIG

Bert Monro

CEO, CORA GOLD
MACIG 2022
West African junior Cora Gold updates GBR on progress at Sanankoro, Mali.
Mining
DRC
MACIG

Conrad Karageorge

CEO, AMANI GOLD
MACIG 2022
Amani Gold updates GBR on progress at its Giro gold project in DRC.
Mining
DRC
MACIG

Oliver Dallaway

DIRECTOR DRC, AFRICAN MINING SERVICES (AMS)
MACIG 2022
AMS comments on serving mines and mining contractors in the DRC.
Mining
DRC
MACIG

Olivier Schorochoff & Weid Vereycken

MANAGING DIRECTOR & REGIONAL MANAGER HAUT-KATANGA AND LUALABA, GARDAWORLD
MACIG 2022
GardaWorld is the largest privately-owned security services company in the world, with an annual turnover of around US$4 billion, a total of 120,000 employees.
Mining
Senegal
MACIG

Andrew Grove

MANAGING DIRECTOR, CHESSER RESOURCES
MACIG 2022
Chesser Resources explains progress at its Diamba Sud project in Senegal.
Mining
Cote d’Ivoire
Senegal
MACIG

Mouhammed Kebe

PARTNER, GENI AND KEBE
MACIG 2022
Gene and Kebe comment on how West Africa is evolving to better welcome investments.
Mining
DRC
MACIG

Navin Dalmia

MANAGING DIRECTOR, RUBAMIN
Rubamin is an Indian company operating in the DRC metals and mining space.
Mining
DRC
MACIG

Weiquan Xia

GENERAL MANAGER, MMG
"On an Africa operations level, we are focused on actively advancing our copper cathode production in the Copperbelt. This strategy is centered on advancing our Kinsevere Expansion Project, which is expected to be approved this year, and then looking beyond to other assets in the region either via acquisition or through exploration."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL